Association between 894G>T endothelial nitric oxide synthase gene polymorphisms and metabolic syndrome

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 52, Issue 8, 2008, Pages 1367-1373

  Piccoli, Jacqueline C Escobar ^a,b   Gottlieb, Maria Gabriela Valle ^a,c   Castro, Luciano ^c   Bodanese, Luiz Carlos ^c   Manenti, Euler Roberto Fernandes ^c   Bogo, Mauricio Reis ^c   Peres, Alessandra ^d   Da Rocha, Maria Izabel U M ^a   Da Cruz, Ivana Beatrice Manica ^a,e  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b DEPARTMENT OF FOOD ENGINEERING   (Brazil)

^c PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d CENTRO UNIVERSITÁRIO METODISTA IPA   (Brazil)

^e Camobi ^*  (United States)

Author keywords

Cardiovascular risk factors; Metabolic disorder; Metabolic syndrome; Nitric oxide synthase; NOS3 polymorphism

Indexed keywords

EID: 58849104920     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302008000800027     Document Type: Article

References (36)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
2. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-421.
3. Alberti KGMM, Zimmet P, Shaw J, for the IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet. 2005;366:1059-62.
4. Cook S, Hugli O, Egli M, Vollenweider P, Burcelin R, Nicod P, et al. Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in NOS3 null mice. Swiss Med Wkly. 2003; 133(25-26):360-3.
5. Napoli C, de Nigris F, Williams-lgnarro S, Pignalosa O, Sica V, Ignarro LJ. Nitric oxide and atherosclerosis: An update. Nitric Oxide 2006; 15:265-79.
6. Naseem KM. The role of nitric oxide in cardiovascular disease. Mol Asp Med. 2005; 26:33-65.
7. Balon TW, Nadler JL. Evidence that nitric oxide increases glucose transport in skeletal muscle. J Appl Physiol. 1997;82 (1):359-63.
8. Higaki A, Ninomiya H, Saji M, Maki H, Koike T, Ohno K. Protective effect of neurotropin against lipopolysaccharide-induced hypotension and lethality linked to suppression of inducible nitric oxide synthase induction. Jpn J Pharmacol. 2001;86 (3):329-35.
9. Pieper GM. Enhanced, unaltered and impaired nitric oxidemediated endothelium-dependent relaxation in experimental diabetes mellitus: importance of disease duration. Diabetol. 1999;42(2):204-13.
10. Marsden PA, Heng HH, Scherer SW, Stewart RJ, Hall AV, Shi XM, et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem. 1993;268:17478-88.
11. Mayer B, Hemmens B. Biosynthesis and action of nitric oxide in mammalian cells. Trends Biochem Sci 1997;22:477-81.
12. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002-12.
13. Stuehr DJ. Structure-function aspects in the nitric oxide synthases. Annu Rev Pharmacol Toxicol. 1997;37:339-59.
14. 298→Asp) is a major risk factor for coronary artery disease in the UK. Circulation. 1999;100:1515-20.
15. Lapu-Bula R, Quarshie A, Lyn D, Oduwole A, Pack C, Morgan J, et al. The 894T allele of endothelial nitric oxide synthase gene is related to left ventricular mass in African Americans with high-normal blood pressure. J Natl Med Assoc. 2005;97 (2):197-205.
16. Iturry-Yamamoto GR, Moriguchi EH, Zago AC, Alho CS, Zago AJ. Association of the 894G>T polymorphism of the endothelial constitutive nitric oxide synthase gene with unstable angina. Braz J Med Biol Res. 2007;40(4):475-83.
17. Piccoli JCE. Estudo associativo entre três polimorfismos (-786T>C, 894G>Te VNTR INTRON 4 a/b) no gene que sintetiza para óxido nítrico sintase endotelial e síndrome coronariana aguda. 2007. [database on the Internet]. Available from:: http://tede.pucrs.br/tde-busca/arquivo.php?codArquivo=836.
18. Hsieh MC, Hsiao JY, Hen KJ, Chang SJ, Lin PC, Hsu SC, et al. The association of endothelial nitric oxide synthase 894G>T polymorphism with C-reactive protein level and metabolic syndrome in a Chinese study group. Metabolism. 2008;57(8): 1125-29.
19. González-Sánchez JL, Martínez-Larrad MT, Sáez ME, Zabena C, Martínez-Calatrava MJ, Serrano-Rios M. Endothelial nitric oxide synthase haplotypes are associated with features of metabolic syndrome. Clin Chem. 2007;53(1):91-7.
20. Fernandez ML, Ruiz R, Gonzalez MA, Ramirez-Lorca R, Couto C, Ramos A, et al. Association of NOS3 gene with metabolic syndrome in hypertensive patients. Thromb Haemost. 2004;92 (2):413-8.
21. Monti LD, Barlassina C, Citterio L, Galluccio E, Berzuini C, Setola E, et al. Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome. Diabetes. 2003;52(5):1270-5.
22. Imamura A, Takahashi R, Murakami R, Kataoka H, Cheng XW, Numaguchi Y, et al. The effects of endothelial nitric oxide synthase gene polymorphisms on endothelial function and metabolic risk factors in healthy subjects: the significance of plasma adiponectin levels. Eur J Endocrinol. 2008; 158(2): 189-95.
23. Little J, Bradley L, Bray MS, Clyne M, Dorman J, Ellsworth DL, et al. Reporting appraising and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol. 2002;156:300-10.
24. Prado-Lima PA, Chatkin JM, Taufer M, Oliveira G, Silveira E, Neto CA, et al. Polymorphism of 5HT2A serotonin receptor gene is implicated in smoking addiction. Am J Med Genet B Neuropsychiatr Genet. 2004;128B (1):90-3.
25. Taufer M, Peres A, de Andrade VM, de Oliveira G, Sá G, do Canto ME, et al. Is the Val16Ala manganese superoxide dismutase polymorphism associated with the aging process? J Gerontol A Biol Sci Med Sci. 2005;60(4):432-8.
26. Gottlieb MG, Schwanke CH, Santos AF, Jobim PF, Müssel DP, da Cruz IB. Association among oxidized LDL levels, MnSOD, apolipoprotein E polymorphisms, and cardiovascular risk factors in a south Brazilian region population. Genet Mol Res. 2005;4(4):691-703.
27. Prado-Lima PS, Cruz IB, Schwanke CH, Netto CA, Licinio J. Human food preferences are associated with a 5-HT(2A) serotonergic receptor polymorphism. Mol Psychiatry. 2006;11(10): 889-91.
28. Schwanke CH, da Cruz IB, Leal NF, Scheibe R, Moriguchi Y, Moriguchi EH. Analysis of the association between apolipoprotein E polymorphism and cardiovascular risk factors in an elderly population with longevity. Arq Bras Cardiol. 2002;78 (6):561-79.
29. Tonks DB. Quality control in clinical laboratories. Warner-Chilcott Laboratories: Scarborough; 1972.
30. Gillerot G, Debaix H, Devuyst O. Genotyping: a new application for the spent dialysate in peritoneal dialysis. Nephr Dial Transpl. 2004;19:1298-301.
31. Nedeljkovic ZS, Gokce N, Loscalzo J. Mechanisms of oxidative stress and vascular dysfunction. Postgrad Med J. 2003; 79:195-200.
32. Pereira AC, Sposito AC, Mota GF, Cunha RS, Herkenhoff FL, Mill JG, et al. Endothelial nitric oxide synthase gene variant modulates the relationship between serum cholesterol levels and blood pressure in the general population: New evidence for a direct effect of lipids in arterial blood pressure. Atheroscl. 2006;184:193-200.
33. Tso AW, Tan KC, Wat NM, Janus ED, Lam TH, S L Lam K. Endothelial nitric oxide synthase 894G>T (Glu298Asp) polymorphism was predictive of glycemic status in a 5-year prospective study of Chinese subjects with impaired glucose tolerance. Metabolism. 2006;55(9):1155-8.
34. Periaswamy R, Gurusamy U, Shewade DG, Cherian A, Swaminathan RP, Dutta TK, et al. Gender specific association of endothelial nitric oxide synthase gene (Glu298Asp) polymorphism with essential hypertension in a south Indian population. Clin Chim Acta. 2008;395 (1-2): 134-6.
35. Brosnihan KB, Li P, Figueroa JP, Ganten D, Ferrario CM. Estrogen, nitric oxide, and hypertension differentially modulate agonist-induced contractile responses in female transgenic (mRen2)27 hypertensive rats. Am J Physiol Heart Circ Physiol. 2008;294(5):H1995-2001.
36. Chakrabarti S, Lekontseva O, Davidge ST. Estrogen is a modulator of vascular inflammation. IUBMB Life. 2008;60(6):376-82.